Treatment of cells with n-alpha-tosyl-l-phenylalanine-chloromethyl ketone induces the proteolytic loss of STAT6 transcription factor

Molecular Immunology

Volumn 45, Issue 15, 2008, Pages 3896-3901

  Perez G, Moises ^a   Cortes, Jose R ^a   Rivas, Maria D ^a   Masa, F ^a   Zamorano, Jose ^a  

^a HOSPITAL SAN PEDRO DE ALCÁNTARA   (Spain)

Author keywords

Alkylation; IL 4; Proteolytic regulation; STAT6; TPCK

Indexed keywords

4 (2 AMINOETHYL)BENZENESULFONYL FLUORIDE; CYSTEINE; INTERLEUKIN 4; PHOSPHATASE; PROTEIN SHC; PROTEINASE INHIBITOR; STAT PROTEIN; STAT5 PROTEIN; STAT6 PROTEIN; THIOL DERIVATIVE; TOSYLPHENYLALANYL CHLOROMETHYL KETONE; TRANSCRIPTION FACTOR REL;

ALKYLATION; ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANIMALS; ANTIOXIDANTS; CELL LINE; MICE; PROTEASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-REL; SHC SIGNALING ADAPTOR PROTEINS; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR; STAT6 TRANSCRIPTION FACTOR; SULFONES; TOSYLPHENYLALANYL CHLOROMETHYL KETONE;

EID: 49449086742     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2008.06.026     Document Type: Article

References (38)

1. Andrews R.P., Ericksen M.B., Cunningham C.M., Daines M.O., and Hershey G.K. Analysis of the life cycle of stat6. Continuous cycling of STAT6 is required for IL-4 signaling. J. Biol. Chem. 277 (2002) 36563-36569
2. Aspord C., Pedrosa-Gonzalez A., Gallegos M., Tindle S., Burton E.C., Su D., Marches F., Bancherau J., and Palucha A.K. Breast cancer instructs dendritic cells to prime interleukin 13-secreting CD4+ T cells that facilitate tumor development. J. Exp. Med. 204 (2007) 1037-1047
3. Ballif B.A., Shimamura A., and Blenis P.E. Disruption of 3-phosphoinositide-dependent kinase 1 (PDK1) signaling by the anti-tumorigenic and anti-proliferative agent n-alpha-tosyl-phenylalanyl chloromethyl ketone. J. Biol. Chem. 276 (2001) 12466-12475
4. Chen X.H., Patel B.K., Wang L.M., Frankel M., Ellmore N., Flavell R.A., LaRochelle W.J., and Pierce J.H. Jak1 expression is required for mediating interleukin-4-induced tyrosine phosphorylation of insulin receptor substrate and Stat6 signaling molecules. J. Biol. Chem. 272 (1997) 6556-6560
5. Citri A., Alroy I., Lavi S., Rubin C., Xu W., Grammatikakis N., Patterson C., Neckers L., Fry D.W., and Yarden Y. Drug-induced ubiquitylation and degradation of ErbB receptor tyrosine kinases: implications for cancer therapy. EMBO. J. 21 (2002) 2407-2417
6. Cui X., Zhang L., Luo J., Rajasekaran A., Hazra S., Cacalano N., and Dubinett S.M. Unphosphorylated STAT6 contributes to constitutive cyclooxigenase-2 expression in human non-small cell lung cancer. Oncogene 26 (2007) 4253-4260
7. Daines M.O., Andrews R.P., Chen W., El-Zayaty S.A., and Hershey G.K. DNA binding activity of cytoplasmic phosphorylated Stat6 is masked by an interaction with a detergent-sensitive factor. J. Biol. Chem. 278 (2003) 30971-30974
8. Finco T.S., Beg A.A., and Baldwin A.S. Inducible phosphorylation of IκBα is not sufficient for its dissociation from NF-κB and is inhibited by protease inhibitors. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 11884-11888
9. Finnegan A., Grusby M.J., Kaplan C.D., O'Neill S.K., Eibel H., Koreny T., Czipri M., Mikeez K., and Zhang J. IL-4 and IL-12 regulate proteoglycan-induced arthritis through Stat-dependent mechanisms. J. Immunol. 169 (2002) 3345-3352
10. Grammer T.C., and Blenis J. The serine protease inhibitors, tosylphenylalanine chloromethyl ketone and tosyllysine chloromethyl ketone, potently inhibit pp70s6k activation. J. Biol. Chem. 271 (1996) 23650-23652
11. Hanson E.M., Dickensheets H., Qu C.K., Donnelly R.P., and Keegan A.D. Regulation of the dephosphorylation of Stat6. Participation of Tyr-713 in the interleukin-4 receptor alpha, the tyrosine phosphatase SHP-1, and the proteasome. J. Biol. Chem. 278 (2003) 3903-3911
12. Hendry L., and John S. Regulation of STAT signaling by proteolytic processing. Eur. J. Biochem. 271 (2004) 4613-4620
13. Heussler V.T., Fernandez P.C., Machado J., Botteron C., and Dobbelaere D.A.E. N-acetylcysteine blocks apoptosis induced by N-α-tosyl-l-phenylalanine chloromethyl ketone in transformed T-cells. Cell Death Differ. 6 (1999) 342-350
14. Karras J.G., Wang Z., Coniglio S.J., Frank D.A., and Rothstein T.L. Antigen-receptor engagement in B cells induces nuclear expression of STAT5 and stat6 proteins that bind and transactivate an IFN-γ activation site. J. Immunol. 157 (1996) 39-47
15. Kelly-Welch A.E., Hanson E.M., Boothby M.R., and Keegan A.D. Interleukin-4 and Interleukin-13 signaling connections maps. Science 300 (2003) 1527-1528
16. Kim S., Wing S.S., and Ponka P. S-nitrosylation of IRP2 regulates its stability via the ubiquitin-proteasome pathway. Mol. Cell. Biol. 24 (2004) 330-337
17. Lee C., Piazza F., Brutsaert S., Valens J., Strehlow I., Jarosinski M., Saris C., and Schindler C. Characterization of the STAT5 protease. J. Biol. Chem. 274 (1999) 26767-26775
18. Lotem J., and Sachs L. Differential suppression by protease inhibitors and cytokines of apoptosis induced by wild-type p53 and cytotoxic agents. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 12507-12512
19. Nelms K., Keegan A.D., Zamorano J., Ryan J.J., and Paul W.E. The IL-4 receptor: signaling mechanisms and biologic functions. Annu. Rev. Immunol. 17 (1999) 701-731
20. Ong E.B., Shaw E., and Schoellmann G. The identification of the histidine residue at the active center of chymotrypsin. J. Biol. Chem. 240 (1965) 694-698
21. O'Shea J.J., Gadina M., and Schreiber R.D. Cytokine signaling in 2002: new surprises in the Jak/Stat pathway. Cell 109 (2002) S121-S131
22. Perez-G M., Melo M., Keegan A.D., and Zamorano J. Aspirin and salicylates inhibit the IL-4- and IL-13-induced activation of STAT6. J. Immunol. 168 (2002) 1428-1434
23. Quelle F.W., Shimoda K., Thierfelder W., Fischer C., Kim A., Ruben S.M., Cleveland J.L., Pierce J.H., Keegan A.D., Nelms K., Paul W.E., and Ihle J.N. Cloning of murine Stat6 and human Stat6, Stat proteins that are tyrosine phosphorylated in responses to IL-4 and IL-13 but are not required for mitogenesis. Mol. Cell. Biol. 15 (1995) 3336
24. Ryan J.J., McReynolds L.J., Huang H., Nelms K., and Paul W.E. Characterization of a mobile Stat6 activation motif in the human IL-4 receptor. J. Immunol. 161 (1998) 1811-1821
25. Seki Y., Hayashi K., Matsumoto A., Seki N., Tsukada J., Ransom J., Naka T., Kishimoto T., Yoshimura A., and Kubo M. Expression of the suppressor of cytokine signaling-5 (SOCS5) negatively regulates IL-4-dependent STAT6 activation and Th2 differentiation. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 13003-13008
26. Shah M., Patel K., Fried V.A., and Sehgal P.B. Interactions of STAT3 with caveolin-1 and heat shock protein 90 in plasma membrane raft and cytosolic complexes. Preservation of cytokine signaling during fever. J. Biol. Chem. 277 (2002) 45662-45669
27. Sherman M.A., Powell D.R., and Brown M.A. IL-4 induces the proteolytic processing of mast cell STAT6. J. Immunol. 169 (2002) 3811-3818
28. Schuster B., Hendry L., Byers H., Lynham S.F., Ward M.A., and John S. Purification and identification of the STAT5 protease in myeloid cells. Biochem. J. 404 (2007) 81-87
29. Suzuki K., Nakajima H., Kagami S., Suto A., Ikeda K., Hirose K., Hiwasa T., Takeda K., Saito Y., Akira S., and Iwamoto I. Proteolytic processing of Stat6 signaling in mast cells as a negative regulatory mechanism. J. Exp. Med. 196 (2002) 27-38
30. Takeda K., Tanaka T., Shi W., Matsumoto M., Minami M., Kashiwamura S., Nakanishi N., Yoshida T., Kishimoto T., and Akira S. Essential role of Stat6 in IL-4 signalling. Nature 380 (1996) 627-630
31. Tomkinson A., Duez C., Cieslewicz G., Pratt J.C., Joetham A., Shanafelt M.C., Gundel R., and Gelfand E.W. A murine IL-4 receptor antagonist that inhibits IL-4- and IL-13-induced responses prevents antigen-induced airway eosinophilia and airway hyperresponsiveness. J. Immunol. 166 (2001) 5780-5792
32. Tsan M.F. Inhibition of neutrophil sulfhydryl groups by chloromethyl ketones. A mechanism for their inhibition of superoxide production. Biochem. Biophys. Res. Commun. 112 (1983) 671-677
33. Urban J.F., Noben-Trauth N., Schopf L., Madden K.B., and Finkelman F.D. Cutting edge: IL-4 receptor expression by non-bone marrow-derived cells is required to expel gastrointestinal nematode parasites. J. Immunol. 167 (2001) 6078-6081
34. Van Noort J.M., Duisterwinkel F.J., Jonak J., Sedlacek J., Kraal B., and Bosch L. The elongation factor Tu.kirromycin complex has two binding sites for tRNA molecules. EMBO J. 1 (1982) 1199-1205
35. Xia Z., Salzier R.R., Kunz D.P., Baer M.R., Kazim L., Baumann H., and Wetzler M. A novel serine-dependent proteolytic activity is responsible for truncated signal transducer and activator of transcription proteins in acute myeloid leukaemia blasts. Cancer Res. 61 (2001) 1747-1753
36. Xu W., Yu F., Yan M., Lu L., Zou W., Sun L., Zheng Z., and Liu X. Geldanamycin, a heat shock protein 90-binding agent, disrupts stat5 activation in IL-2-stimulated cells. J. Cell. Physiol. 2 (2004) 188-196
37. 6-alkylguanine-DNA alkyltransferase. Carcinogenesis 23 (2002) 823-830
38. Zamorano J., Rivas M.D., Setien F., and Perez-G M. Proteolytic regulation of activated STAT6 by calpains. J. Immunol. 174 (2005) 2843-2848